Literature DB >> 15778022

Genotyping of the fish rhabdovirus, viral haemorrhagic septicaemia virus, by restriction fragment length polymorphisms.

Katja Einer-Jensen1, James Winton, Niels Lorenzen.   

Abstract

The aim of this study was to develop a standardized molecular assay that used limited resources and equipment for routine genotyping of isolates of the fish rhabdovirus, viral haemorrhagic septicaemia virus (VHSV). Computer generated restriction maps, based on 62 unique full-length (1524 nt) sequences of the VHSV glycoprotein (G) gene, were used to predict restriction fragment length polymorphism (RFLP) patterns that were subsequently grouped and compared with a phylogenetic analysis of the G-gene sequences of the same set of isolates. Digestion of PCR amplicons from the full-length G-gene by a set of three restriction enzymes was predicted to accurately enable the assignment of the VHSV isolates into the four major genotypes discovered to date. Further sub-typing of the isolates into the recently described sub-lineages of genotype I was possible by applying three additional enzymes. Experimental evaluation of the method consisted of three steps: (i) RT-PCR amplification of the G-gene of VHSV isolates using purified viral RNA as template, (ii) digestion of the PCR products with a panel of restriction endonucleases and (iii) interpretation of the resulting RFLP profiles. The RFLP analysis was shown to approximate the level of genetic discrimination obtained by other, more labour-intensive, molecular techniques such as the ribonuclease protection assay or sequence analysis. In addition, 37 previously uncharacterised isolates from diverse sources were assigned to specific genotypes. While the assay was able to distinguish between marine and continental isolates of VHSV, the differences did not correlate with the pathogenicity of the isolates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778022     DOI: 10.1016/j.vetmic.2004.12.008

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  A single amino acid mutation (I1012F) of the RNA polymerase of marine viral hemorrhagic septicemia virus changes in vitro virulence to rainbow trout gill epithelial cells.

Authors:  Sung-Hyun Kim; Beate J Thu; Helle F Skall; Niccolò Vendramin; Oystein Evensen
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

2.  Genotyping and pathogenicity of viral hemorrhagic septicemia virus from free-living turbot (Psetta maxima) in a Turkish coastal area of the Black Sea.

Authors:  Toyohiko Nishizawa; Haci Savas; Hakan Isidan; Cennet Ustündağ; Hiroshi Iwamoto; Mamoru Yoshimizu
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

3.  RNA aptamers inhibit the growth of the fish pathogen viral hemorrhagic septicemia virus (VHSV).

Authors:  Porntep Punnarak; Mudjekeewis D Santos; Seong Don Hwang; Hidehiro Kondo; Ikuo Hirono; Yo Kikuchi; Takashi Aoki
Journal:  Mar Biotechnol (NY)       Date:  2012-04-22       Impact factor: 3.619

4.  Distribution of an invasive aquatic pathogen (viral hemorrhagic septicemia virus) in the Great Lakes and its relationship to shipping.

Authors:  Mark B Bain; Emily R Cornwell; Kristine M Hope; Geofrey E Eckerlin; Rufina N Casey; Geoffrey H Groocock; Rodman G Getchell; Paul R Bowser; James R Winton; William N Batts; Allegra Cangelosi; James W Casey
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

5.  Complete genome sequence of viral hemorrhagic septicemia virus isolated from an olive flounder in South Korea.

Authors:  Jong-Oh Kim; Wi-Sik Kim; Toyohiko Nishizawa; Myung-Joo Oh
Journal:  Genome Announc       Date:  2013-09-05

6.  Molecular characterization of the Great Lakes viral hemorrhagic septicemia virus (VHSV) isolate from USA.

Authors:  Arun Ammayappan; Vikram N Vakharia
Journal:  Virol J       Date:  2009-10-25       Impact factor: 4.099

7.  Virulence of viral haemorrhagic septicaemia virus (VHSV) genotype III in rainbow trout.

Authors:  Takafumi Ito; Jun Kurita; Koh-ichiro Mori; Niels J Olesen
Journal:  Vet Res       Date:  2016-01-08       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.